About The Position

The HS Scientific Strategy Lead will lead the commercial scientific strategy for the company's investigational monoclonal antibody tulisokibart in hidradenitis suppurativa (HS). The role translates complex science, clinical evidence and customer insight into a differentiated, credible scientific narrative, while ensuring that evidence generation and scientific engagement support the global commercial ambition, Phase 3 program and launch readiness. Working across Commercial, Medical Affairs, Clinical Development, Outcomes Research, Global Market Access, Policy and priority markets, the position will shape evidence priorities, scientific leader engagement, congress strategy and communications. It will also support early Dermatology pipeline and business development assessments, manage relevant agency relationships and budgets, and report progress, risks and recommendations to the Executive Director, Global Commercial Lead, Hidradenitis Suppurativa. The role is based in Rahway, New Jersey, with hybrid work arrangements and 25% travel.

Requirements

  • Bachelor's degree in life sciences or a related field.
  • At least 10 years of progressive experience in marketing, sales, market access, medical-commercial collaboration or related roles in the pharmaceutical or biotechnology industry, including at least 5 years of demonstrated in-line or global-relevant experience.
  • At least 2 years of immunology experience, with demonstrated ability to understand and translate complex scientific and clinical information into actionable commercial strategy.
  • Demonstrated experience developing scientific narratives, evidence strategies, scientific leader engagement or commercial input to clinical development and data generation.
  • Strong strategic leadership, analytical and problem-solving skills, including the ability to make choices under uncertainty and translate insights into clear priorities.
  • Ability to collaborate with and influence cross-functional teams and senior stakeholders without direct line authority.
  • Exceptional written, verbal and presentation skills, with ability to communicate across scientific, commercial and senior leadership audiences.
  • Ability to operate effectively across cultures and geographies in a complex global matrix.
  • Learning agility, curiosity, inclusive leadership and commitment to challenging the status quo to improve outcomes.
  • Required skills listed: Agile Methodology, Biotechnology, Decision Making, Dermatology, Digital Marketing, Financial Acumen, Immunology Research, Learning Agility, Life Science, Market Research, Medical Affairs, Presentation Delivery, Pricing Strategies, Strategic Planning and Strategic Thinking.

Nice To Haves

  • Advanced degree in business, science or a related discipline, such as an MBA, MSc, PharmD or PhD.
  • Hidradenitis suppurativa or dermatology experience, including understanding of the HS patient journey, treatment landscape, clinical endpoints and unmet need.
  • Experience building scientific strategy for a novel mechanism of action and shaping evidence generation with Medical Affairs, Clinical Development and Outcomes Research.
  • Experience leading scientific leader engagement, advisory boards, congress strategy and scientific communication planning.
  • Global or US launch experience and multi-country engagement.
  • Experience working with pipeline assets from Phase 2 through Phase 3 and launch readiness.
  • Experience operating within pharmaceutical promotional, medical and compliance review processes and maintaining clear commercial/medical accountabilities.

Responsibilities

  • Lead and evolve the global commercial scientific strategy for tulisokibart in HS, aligned with the integrated global brand strategy and broader Dermatology ambition.
  • Develop a clear, concise and differentiated scientific narrative for TL1A and its potential immuno-fibrotic biology in HS, communicating evidence appropriately and without claims beyond the data.
  • Partner with Medical Affairs, Clinical Development, Research Laboratories, Outcomes Research and Global Market Access to identify and prioritize evidence gaps that may affect treatment positioning, access and commercial value.
  • Represent Commercial in evidence-planning forums and provide commercial input to Phase 3 design, endpoints, patient-relevant outcomes, sub-populations and evidence-generation plans.
  • Lead commercial scientific landscape assessments covering treatment guidelines, evolving endpoints, competitive mechanisms and emerging standards of disease control in HS.
  • Develop the global scientific leader engagement strategy with Medical Affairs, including expert mapping, insight plans, scientific input forums and engagement with HS, dermatology, surgery and multidisciplinary-care experts.
  • Partner with Medical Affairs to design and execute Scientific Expert Input forums that test the development plan, scientific narrative, value hypotheses and evidence priorities.
  • Lead commercial congress strategy and cross-functional congress planning, including scientific priorities, insight generation, competitor monitoring, internal briefings and senior leadership scientific engagements.
  • Work with Value & Implementation colleagues and US and priority international markets to ensure evidence priorities reflect clinical practice, access environments and implementation barriers.
  • Create the scientific communication roadmap supporting Phase 3 milestones and launch readiness, ensuring consistency across global, regional and local teams.
  • Support external engagement with professional societies, guideline stakeholders, patient organisations and other external partners in collaboration with Medical, Policy and Communications.
  • Apply advanced analytics, AI-enabled insight synthesis and structured decision-making to identify emerging evidence, competitor activity and strategic implications.
  • Manage relevant agency relationships, projects and budgets, ensuring high-quality delivery against agreed milestones.
  • Contribute to early Dermatology pipeline and business development assessments by evaluating scientific differentiation, evidence requirements and strategic fit.
  • Establish scientific-strategy deliverables, decision milestones and success measures; communicate progress, risks and recommendations to the Global Commercial Lead, HS and cross-functional leadership team.
  • Partner with the HCP Strategy Lead to translate the scientific narrative and evidence accurately into positioning, message strategy, campaign development and customer engagement.

Benefits

  • Medical, dental and vision healthcare benefits.
  • Other insurance benefits for employees and family.
  • Retirement benefits, including a 401(k).
  • Paid holidays.
  • Vacation.
  • Compassionate and sick days.
  • Eligible for an annual bonus and long-term incentive, if applicable.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service